|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03494790 |
|
Date of registration:
|
04/04/2018 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Markers of Inflammation and Metabolism in the ER
MIMER |
|
Scientific title:
|
Markers of Inflammation and Metabolism in the ER |
|
Date of first enrolment:
|
December 15, 2017 |
|
Target sample size:
|
955 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03494790 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Finland
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Age 18 or more Suspected or confirmed infection Admitted to any of the three emergency
departments of university hospital Decision of blood culture
Exclusion Criteria:
Age <18 Cancer with metastases Decision of treatment limitation probable or made Consent
not obtainable
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Acute Infection
|
|
Sepsis
|
|
Primary Outcome(s)
|
|
Days alive without intensive care or high dependency unit treatment
[Time Frame: 2 weeks from study admission]
|
|
Secondary Outcome(s)
|
|
90 day mortality
[Time Frame: 90 days]
|
|
30 day mortality
[Time Frame: 30 days]
|
|
Secondary ID(s)
|
|
HelsinkiU1423/2017
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|